Eden Research (LON:EDEN) Reaches New 12-Month Low – Here’s What Happened
by Amy Steele · The Cerbat GemEden Research plc (LON:EDEN – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as GBX 1.93 and last traded at GBX 2, with a volume of 1112218 shares. The stock had previously closed at GBX 2.15.
Eden Research Trading Down 7.0%
The company’s fifty day moving average price is GBX 2.46 and its 200-day moving average price is GBX 2.98. The stock has a market cap of £16.07 million, a price-to-earnings ratio of -4.51 and a beta of 1.61. The company has a debt-to-equity ratio of 5.41, a current ratio of 1.95 and a quick ratio of 2.42.
Eden Research (LON:EDEN – Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share (EPS) for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. On average, research analysts expect that Eden Research plc will post -66.0000038 EPS for the current fiscal year.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.